A Phase 1 Study to Determine the Safety, Tolerability and Pharmacokinetics of 177Lu-EVG321 in Patients with Small Cell Lung Cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518039-12-00

Acronym

EVG001AT101

Enrollment

Registered

2025-02-05

Start date

2025-05-27

Completion date

Unknown

Last updated

2025-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small Cell Lung Cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Austria, Italy

None listed

Source: EU CTIS · Data processed: Feb 4, 2026